Oculis completes patient recruitment for stage 1 of Phase 3 DIAMOND study evaluating the efficacy and safety of OCS-01 in diabetic macular edema (DME) Oculis completes patient recruitment for stage 1 of Phase 3 DIAMOND study evaluating the efficacy and safety of OCS-01 in diabetic macular edema (DME) Oculis has completed enrollment for stage 1...

Retina-Vitreous Associates Medical Group Offers Patients First FDA Approved Non-Surgical Therapy for Sight Threatening Condition BEVERLY HILLS, Calif., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Retina-Vitreous Associates Medical Group, nationally recognized leaders that specialize in the treatment of diseases affecting the retina, are...